Drugs / Trivalent Inactivated Influenza Virus
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01701752 Comparator | Sep 2012 → Apr 2013 | influenza | Immune Targeting Systems Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent Inactivated Influenza Virus | “Trivalent Inactivated Influenza Virus (TIV) vaccine” NCT01701752 ↗ |
| Known as | TIV | “Trivalent Inactivated Influenza Virus (TIV) vaccine” NCT01701752 ↗ |
| Modality | Vaccine | “Trivalent Inactivated Influenza Virus (TIV) vaccine” NCT01701752 ↗ |